Insurance Denials, Delays Limit Pediatric Asthma Biologics
Approximately 40% of insurance requests for pediatric asthma biologic therapies are denied, with approvals taking more than a month on average.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
FDA Clears Roche cobas eplex RP3 Respiratory Test Panel
The Roche cobas eplex RP3 identifies up to 19 viral and bacterial pathogens in under two hours, giving healthcare teams flexible diagnostic options.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
CHEST Developing Pulmonary Certification Program for Advanced Practice Providers
The American College of Chest Physicians announced plans to create the first pulmonary-focused education and certification program for advanced practice providers.
Pharmaceuticals
Latest
Mepolizumab Reduced Corticosteroid Use in COPD Patients
Analysis of Phase 3 clinical trials shows mepolizumab cuts annual steroid exposure and high-dose treatment days for COPD patients.
Diagnostics & Testing
Latest
Exhaled Breath, Blood Tests Differentiate Lung Diseases
Distinct lipid signatures identified in blood plasma and exhaled breath samples can differentiate between IPF and fibrotic hypersensitivity pneumonitis.
Monitoring & Treatment
Latest
Resmed Introduces Full Face Fabric CPAP Mask
Resmed announced the US introduction of its AirTouch F40, a fabric, full face CPAP mask option. It will be commercially available starting October 28, 2026.